The Patent Finder

Bodor Laboratories, Inc.

Also on record
Records under this name other than the patents Bodor Laboratories, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 33 patents it holds.

Showing 1 to 5 of 5 · Back to Bodor Laboratories, Inc.

PatentTitleStatus Expires Confidence
US 8,628,759Soft Anticholinergic Esters
Term ended
Term ended Nov 13, 2026 · Medium confidence
Term endedTerm ended Nov 13, 2026Medium confidence
US 8,835,410Treatment of Eyelid Dermatitis
Lapsed on the fee record
Ended Sep 16, 2026 · High confidence
Lapsed on the fee recordEnded Sep 16, 2026High confidence
US 7,419,971Enhancement of activity and/or duration of action of selected anti-inflammatory steroids for topical or other local application
Term ended
Term ended Sep 14, 2025 · From the USPTO record
Term endedTerm ended Sep 14, 2025From the USPTO record
US 7,923,441Enhancement of activity and/or duration of action of soft anti-inflammatory steroids for topical or other local application
Term ended
Term ended Oct 16, 2024 · From the USPTO record
Term endedTerm ended Oct 16, 2024From the USPTO record
US 7,776,846Enhancement of activity and/or duration of action of selected anti-inflammatory steroids for topical or other local application
Lapsed on the fee record
Ended Aug 17, 2022 · From the USPTO record
Lapsed on the fee recordEnded Aug 17, 2022From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited